Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 20:5:54.
doi: 10.3389/fnins.2011.00054. eCollection 2011.

Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract

Affiliations

Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract

Roeland Buckinx et al. Front Neurosci. .

Abstract

Corticotrophin-releasing factor (CRF) is mainly known for its role in the stress response in the hypothalamic-pituitary-adrenal axis. However, increasing evidence has revealed that CRF receptor signaling has additional peripheral effects. For instance, activation of CRF receptors in the gastrointestinal tract influences intestinal permeability and motility. These receptors, CRF1 and CRF2, do not only bind CRF, but are also activated by urocortins. Most interestingly, CRF-related signaling also assumes an important role in inflammatory bowel diseases in that it influences inflammatory processes, such as cytokine secretion and immune cell activation. These effects are characterized by an often contrasting function of CRF1 and CRF2. We will review the current data on the expression of CRF and related peptides in the different regions of the gastrointestinal tract, both in normal and inflamed conditions. We next discuss the possible functional roles of CRF signaling in inflammation. The available data clearly indicate that CRF signaling significantly influences inflammatory processes although there are important species and inflammation model differences. Although further research is necessary to elucidate this apparently delicately balanced system, it can be concluded that CRF-related peptides and receptors are (certainly) important candidates in the modulation of gastrointestinal inflammation.

Keywords: corticotrophin-releasing factor; gastrointestinal tract; inflammation; urocortin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic overview of the expression of CRF-related proteins in the stomach. Regular font indicates that protein expression has been described, italic font indicates that mRNA expression has been described, bold font indicates that expression has been described at mRNA and protein level. MP, myenteric plexus; SP, submucous plexus; r, rat; m, mouse; gp, guinea pig; h, human; o, ovine fetus.
Figure 2
Figure 2
Schematic overview of the expression of CRF-related proteins in the small intestine. Regular font indicates that protein expression has been described, italic font indicates that mRNA expression has been described, bold font indicates that expression has been described at mRNA and protein level. MP, myenteric plexus; SP, submucous plexus; r, rat; m, mouse; gp, guinea pig; h, human; o, ovine fetus.
Figure 3
Figure 3
Schematic overview of the expression of CRF-related proteins in the colon. Regular font indicates that protein expression has been described, italic font indicates that mRNA expression has been described, bold font indicates that expression has been described at mRNA and protein level. MP, myenteric plexus; SP, submucous plexus; r, rat; m, mouse; gp, guinea pig; h, human; o, ovine fetus.

Similar articles

Cited by

References

    1. Anton P. M., Gay J., Mykoniatis A., Pan A., O'Brien M., Brown D., Karalis K., Pothoulakis C. (2004). Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc. Natl. Acad. Sci. U.S.A. 101, 8503–8508 - PMC - PubMed
    1. Arai M., Assil I. Q., Abou-Samra A. B. (2001). Characterization of three corticotropin-releasing factor receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 142, 446–45410.1210/en.142.1.446 - DOI - PubMed
    1. Araki A., Kanai T., Ishikura T., Makita S., Uraushihara K., Iiyama R., Totsuka T., Takeda K., Akira S., Watanabe M. (2005). MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16–2310.1007/s00535-004-1492-9 - DOI - PubMed
    1. Ardati A., Goetschy V., Gottowick J., Henriot S., Valdenaire O., Deuschle U., Kilpatrick G. J. (1999). Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology 38, 441–44810.1016/S0028-3908(98)00201-9 - DOI - PubMed
    1. Bale T. L., Giordano F. J., Hickey R. P., Huang Y., Nath A. K., Peterson K. L., Vale W. W., Lee K. F. (2002). Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc. Natl. Acad. Sci. U.S.A. 99, 7734–7739 - PMC - PubMed

LinkOut - more resources